Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rheumatoid Arthritis(RA)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02551575
What this trial is testing

Efficacy and Safety of Traditional Chinese Medicine (TCM) Comprehensive Therapy in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 468
Testing effectiveness (Phase 2)Study completedNCT01250548
What this trial is testing

The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment (CARAT)

Who this might be right for
Rheumatoid Arthritis
Baylor Research Institute 34
Post-approval studies (Phase 4)Study completedNCT01770106
What this trial is testing

RA Denosumab on Bone Microstructure Study

Who this might be right for
Rheumatoid Arthritis
Chinese University of Hong Kong 40
Not applicableUnknownNCT00747578
What this trial is testing

Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan

Who this might be right for
Rheumatoid ArthritisSystemic Lupus ErythematosusAnkylosing Spondylitis
Taichung Veterans General Hospital 300
Early research (Phase 1)Study completedNCT01417052
What this trial is testing

Determine the Safety and Efficacy of LX3305 in Subjects With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Lexicon Pharmaceuticals 10
Post-approval studies (Phase 4)Study completedNCT03505008
What this trial is testing

Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan

Who this might be right for
Rheumatoid Arthritis
Keio University 300
Not applicableStudy completedNCT04749160
What this trial is testing

Smart Marker Annunciating Response to Rheumatologic Treatments SMART²T

Who this might be right for
Rheumatoid Arthritis
Centre Hospitalier Universitaire de Saint Etienne 26
Post-approval studies (Phase 4)Study completedNCT00396747
What this trial is testing

A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study

Who this might be right for
Rheumatoid Arthritis
Université Catholique de Louvain 45
Large-scale testing (Phase 3)Study completedNCT01272908
What this trial is testing

MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 120
Large-scale testing (Phase 3)Ended earlyNCT01215942
What this trial is testing

An Open Label Study for Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 1,086
Large-scale testing (Phase 3)Study completedNCT02640612
What this trial is testing

Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Boehringer Ingelheim 430
Large-scale testing (Phase 3)Study completedNCT02046603
What this trial is testing

Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 162
Testing effectiveness (Phase 2)UnknownNCT06306339
What this trial is testing

Assess the Efficacy and Safety of Burfiralimab (hzVSF-v13) and DMRD (Disease-modifying Antirheumatic Drug)

Who this might be right for
Moderate to Severe Rheumatoid Arthritis
ImmuneMed, Inc. 60
Testing effectiveness (Phase 2)Ended earlyNCT03001219
What this trial is testing

RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 109
Large-scale testing (Phase 3)Study completedNCT02873936
What this trial is testing

Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences 449
Early research (Phase 1)Study completedNCT02535832
What this trial is testing

Skeletal Muscle Dysfunction in Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid ArthritisInsulin Resistance
Ohio State University 16
Not applicableUnknownNCT03456206
What this trial is testing

Chronic Inflammatory Disease, Lifestyle and Risk of Disease

Who this might be right for
Autoimmune DiseasesInflammatory Bowel DiseasesCrohn Disease (CD)+6 more
University of Southern Denmark 57,053
Not applicableUnknownNCT02320630
What this trial is testing

Combination Therapy Prevents the Relapse of RA

Who this might be right for
Recurrence (Disease Attribute)
Peking University First Hospital 240
Not applicableLooking for participantsNCT07150000
What this trial is testing

Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy

Who this might be right for
Rheumatic DiseasesRheumatoid Arthritis (RA)Giant Cell Arteritis (GCA)+10 more
University of Bonn 120
Testing effectiveness (Phase 2)Study completedNCT00713544
What this trial is testing

A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AstraZeneca 373
Next Page